For the quarter ending 2026-01-31, ODYY has $721,304 in assets.
| Balance Sheets | 2026-01-31 | 2025-10-31 | 2025-07-31 | |
|---|---|---|---|---|
| Cash | 616,327 | 25,586 | 19,084 | |
| Research and development rebate due from australian government, net | - | - | 0 | |
| Prepaid expenses and other current assets, net | 104,977 | 118,036 | 30,639 | |
| Total current assets | 721,304 | 143,622 | 49,723 | |
| Investment in oragenics, inc. common stock, at fair value | - | - | 0 | |
| Total assets | 721,304 | 143,622 | 49,723 | |
| Accounts payable and accrued wages | 1,620,079 | 1,688,642 | 1,615,357 | |
| Accounts payable and accrued wages, officers | 1,857,004 | 1,890,751 | 1,858,443 | |
| Accrued interest | 509,348 | 395,775 | 421,440 | |
| Asset purchase liability | 1,125,026 | 1,125,026 | 1,125,026 | |
| Convertible notes payable, officers and directors | - | 100,000 | - | |
| Notes payable, net | - | 394,222 | - | |
| Notes payable, officers and directors | 100,000 | - | 100,000 | |
| Convertible notes payable, net | - | 1,479,239 | - | |
| Notes payable, net of unamortized debt discount and closing costs of 3,122,747 and 512, respectively | 2,169,500 | - | 1,884,155 | |
| Derivative liabilities | 3,936,166 | 225,155 | - | |
| Total current liabilities | 11,317,123 | 7,298,810 | 7,004,421 | |
| Common stock, 0.001 par value, 500,000,000 shares authorized, 99,853,763 and 96,709,763 shares issued and outstanding as of january 31, 2026 and july 31, 2025, respectively | 99,854 | 99,854 | 96,710 | |
| Additional paid-in capital | 56,135,234 | 55,974,242 | 55,694,429 | |
| Accumulated deficit | -66,830,907 | -63,229,284 | -62,745,837 | |
| Total stockholders deficit | -10,595,819 | -7,155,188 | -6,954,698 | |
| Total liabilities and stockholders deficit | 721,304 | 143,622 | 49,723 | |
Odyssey Health, Inc. (ODYY)
Odyssey Health, Inc. (ODYY)